Fall 2023
November 16, 2023 (Declaration Forms due by November 8)
Spring 2024
February 29, 2024 (Declaration Forms due by February 22)
May 3, 2024 (Declaration Forms due by April 26)
To request review of your proposed research project by the IBC, complete the Biohazardous Materials Declaration form or the Exempt Protocol Request form and other documents as related to your research. The signed and approved PDF of the protocol, including all attachments, must be submitted to Michele Smith, Grants and Sponsored Research Development, by the submission deadlines published above in order to be considered at that meeting. Protocols received after the submission deadline will be reviewed at the next scheduled meeting. Additional forms that may need to be completed:
All members of the research team, including the primary investigator, co-researchers,
research assistants, and/or faculty advisors must complete CITI Biosafety / Biosecurity
training before submitting a protocol for IBC review.
Required Training Course: Basic Biosafety Training
CITI Training Site [Instructions for CITI Training Site]
Institutional Biosafety Committee (IBC) Policy and Procedures (PDF - 282 KB)
The Institutional Biosafety Committee (IBC) oversees the safety of research and classroom
projects involving recombinant DNA or other biohazardous materials. The IBC sets containment
levels in accordance with National Institutes of Health Guidelines and the Center
for Disease Control and Prevention. The IBC periodically reviews previously approved
research projects for changes which would necessitate increasing or decreasing the
containment levels.
Specifically, the IBC evaluates research projects that use recombinant DNA or other
biohazardous materials. The IBC coordinates its reviews with University departmental
laboratory safety committees and Safety Officers in order to ensure research personnel
have adequate occupational health monitoring and training on safe work practices,
exposure control emergencies, and the use of protective equipment.
American Biological Safety Association (ABSA) Risk Group Classification for Infectious
Agents
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
(NIH Guidelines)
Investigator Responsibilities Under the NIH Guidelines
CDC Biosafety in Microbiological and Biomedical Laboratories
Select Agent Rule
World Health Organization - Laboratory BioSafety Manual
